Staphylococcus aureus bacteremia (SAB) is an important infection with an incidence rate
ranging from 20 to 50 cases/100,000 population per year. Between 10% and 30% of these …

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-and
community-associated infections worldwide. Within the healthcare setting alone, MRSA …

Multidrug-resistant organisms (MDROs), including methicillin-resistant Staphylococcus
aureus (MRSA), vancomycin-resistant enterococci (VRE), and certain gram-negative bacilli …

Antibiotic resistance continues to plague antimicrobial chemotherapy of infectious disease.
And while true biocide resistance is as yet unrealized, in vitro and in vivo episodes of …

Staphylococcus aureus frequently causes infections that are challenging to treat, leading to
high rates of persistent and relapsing infection. Here, to understand how the host …

Background. Asymptomatic colonization with methicillin-resistant Staphylococcus aureus
(MRSA) has been described as a risk factor for subsequent MRSA infection. MRSA is an …

Background Environmental contamination with methicillin-resistantStaphylococcus aureus
(MRSA) and vancomycin-resistant enterococci (VRE) occurs during the care of patients …

Daptomycin is the first available agent from a new class of antibiotics, the cyclic lipopeptides,
that has activity against a broad range of gram-positive pathogens, including organisms that …

Staphylococcus aureus is a major cause of bacteremia, and S. aureus bacteremia is
associated with higher morbidity and mortality, compared with bacteremia caused by other …

Background. Whether community-associated methicillin-resistant Staphylococcus aureus
(MRSA) genotypes (eg, USA300) are a major cause of bloodstream infections (BSIs) and …